|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
5
|
Zenith Epigenetics
|
Jan 30, 2019 12:14PM
|
|
Re: Answer from IR - 250 confrimed MACE would require disclosure
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 12:51PM
|
|
Re: Sarah's reply to my email
|
8
|
Resverlogix Corp.
|
Jan 31, 2019 08:11PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
7
|
Resverlogix Corp.
|
Jan 31, 2019 10:00PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
7
|
Resverlogix Corp.
|
Jan 31, 2019 10:29PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
3
|
Resverlogix Corp.
|
Jan 31, 2019 10:59PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
4
|
Resverlogix Corp.
|
Jan 31, 2019 11:23PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
1
|
Resverlogix Corp.
|
Jan 31, 2019 11:53PM
|
|
Re: My email to Sarah...the latest
|
4
|
Resverlogix Corp.
|
Feb 01, 2019 01:37AM
|
|
Re: My email to Sarah...the latest
|
4
|
Resverlogix Corp.
|
Feb 01, 2019 09:47AM
|
|
Re: AACR 2019
|
7
|
Zenith Epigenetics
|
Feb 28, 2019 02:07PM
|
|
Re: MACE Events - Statistically Confusing
|
2
|
Resverlogix Corp.
|
Mar 01, 2019 10:57AM
|
|
Re: Why I think it's a homerun
|
4
|
Resverlogix Corp.
|
Mar 03, 2019 04:11PM
|
|
Re: Why I think it's a homerun
|
3
|
Resverlogix Corp.
|
Mar 03, 2019 08:51PM
|
|
Re: Why I think it's a homerun
|
2
|
Resverlogix Corp.
|
Mar 04, 2019 12:03PM
|
|
Re: What if
|
4
|
Resverlogix Corp.
|
Mar 07, 2019 10:53AM
|
|
Re: What if
|
3
|
Resverlogix Corp.
|
Mar 07, 2019 11:49AM
|
|
Re: What if
|
4
|
Resverlogix Corp.
|
Mar 08, 2019 11:05AM
|
|
Re: What if
|
4
|
Resverlogix Corp.
|
Mar 08, 2019 11:17AM
|
|
Re: I don’t get it
|
6
|
Resverlogix Corp.
|
May 26, 2019 05:21PM
|
